R. Andrew's most recent trade in Arvinas Inc was a trade of 11,139 Common Stock done at an average price of $9.9 . Disclosure was reported to the exchange on May 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arvinas Inc | Andrew R. Saik | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.94 per share. | 11 May 2026 | 11,139 | 193,128 (0%) | 0% | 9.9 | 110,693 | Common Stock |
| 1stdibs.com Inc | Andrew G. Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2026 | 26,798 | 26,798 | - | - | Restricted Stock Units | |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 19.35 per share. | 08 May 2026 | 3,000 | 14,376 (0%) | 0% | 19.3 | 58,036 | Common Stock, par value $0.01 per share |
| Sterling infra Inc | B. Andrew Rose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 181 | 654 (0%) | 0% | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, Chairman & CEO, Skyward Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 20,150 | 187,824 | - | 0 | Common Stock | |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Sale of securities on an exchange or to another person at price $ 918.71 per share. | 06 May 2026 | 15,674 | 52,935 (0%) | 0% | 918.7 | 14,399,861 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, Chairman & CEO, Skyward Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 15,151 | 0 | - | - | 2023 LTIP - PSUs | |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 253.98 per share. | 06 May 2026 | 11,655 | 64,590 (0%) | 0% | 254.0 | 2,960,137 | Common Stock |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 11,655 | 0 | - | - | Employee Stock Options | |
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, Chairman & CEO, Skyward Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.68 per share. | 06 May 2026 | 7,930 | 179,894 | - | 43.7 | 346,382 | Common Stock |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 7,673 | 3,836 | - | - | Employee Stock Options | |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 338.65 per share. | 06 May 2026 | 7,673 | 72,263 (0%) | 0% | 338.6 | 2,598,461 | Common Stock |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Payment of exercise price or tax liability using portion of securities received from the company at price $ 920.72 per share. | 06 May 2026 | 7,380 | 68,609 (0%) | 0% | 920.7 | 6,794,914 | Common Stock |
| TFS Fin Corp | Andrew James Rubino | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.18 per share. | 06 May 2026 | 6,600 | 21,310 (0%) | 0% | 15.2 | 100,188 | Common Stock |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 3,726 | 7,450 | - | - | Employee Stock Options | |
| Caterpillar | Andrew Robert John Bonfield | CFO Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 332.04 per share. | 06 May 2026 | 3,726 | 75,989 (0%) | 0% | 332.0 | 1,237,181 | Common Stock |
| Trupanion Inc | Darryl Graham Andrew Rawlings | Director | Other type of transaction at price $ 0.00 per share. | 06 May 2026 | 1,359 | 1,435,340 (4%) | 0% | - | Common Stock | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 04 May 2026 | 31,352 | 2,175,766 (0%) | 0% | 275 | 8,621,800 | Common Stock, par value $.01 per share |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2026 | 5,000 | 44,444 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.27 per share. | 01 May 2026 | 5,000 | 46,382 (0%) | 0% | 52.3 | 261,350 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 232.92 per share. | 01 May 2026 | 1,420 | 42,182 (0%) | 0% | 232.9 | 330,749 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 228.75 per share. | 01 May 2026 | 932 | 44,850 (0%) | 0% | 228.8 | 213,198 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 234.02 per share. | 01 May 2026 | 800 | 41,382 (0%) | 0% | 234.0 | 187,214 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 232.04 per share. | 01 May 2026 | 780 | 43,602 (0%) | 0% | 232.0 | 180,991 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 227.45 per share. | 01 May 2026 | 600 | 45,782 (0%) | 0% | 227.5 | 136,470 | Common Stock |
| Greif Inc (Class A) | B. Andrew Rose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 402 | 3,313 | - | - | Phantom Stock Units (Cash Only Rights) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 230.87 per share. | 01 May 2026 | 370 | 44,382 (0%) | 0% | 230.9 | 85,422 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 229.70 per share. | 01 May 2026 | 98 | 44,752 (0%) | 0% | 229.7 | 22,511 | Common Stock |
| ARKO Petroleum Corp Ordinary | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2026 | 7,559 | 7,559 | - | 0 | Class A common Stock, par value $0.0001 per share | |
| Camden National Corp | Andrew R. Forbes | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.97 per share. | 29 Apr 2026 | 127 | 6,020 (0%) | 0% | 48.0 | 6,092 | Common Stock |
| Camden National Corp | Andrew R. Forbes | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.16 per share. | 29 Apr 2026 | 97 | 5,923 (0%) | 0% | 48.2 | 4,672 | Common Stock |
| Camden National Corp | Andrew R. Forbes | EVP | Grant, award, or other acquisition of securities at price $ 50.67 per share. | 28 Apr 2026 | 1,036 | 6,147 (0%) | 0% | 50.7 | 52,494 | Common Stock |
| J.Jill Inc | Andrew Rolfe | Director | Other type of transaction at price $ 0.00 per share. | 28 Apr 2026 | 56 | 27,684 (0%) | 0% | 0 | Common Stock | |
| Camden National Corp | Andrew R. Forbes | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.68 per share. | 24 Apr 2026 | 149 | 5,111 (0%) | 0% | 49.7 | 7,402 | Common Stock |
| Camden National Corp | Andrew R. Forbes | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.68 per share. | 24 Apr 2026 | 90 | 5,260 (0%) | 0% | 49.7 | 4,471 | Common Stock |
| Parker-Hannifin | Andrew D. Ross | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2026 | 9,837 | 22,957 (0%) | 0% | 0 | Common Stock | |
| Parker-Hannifin | Andrew D. Ross | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 954.43 per share. | 22 Apr 2026 | 4,339 | 18,618 (0%) | 0% | 954.4 | 4,141,272 | Common Stock |
| Suncrete Inc Ordinary | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 48,000 | 48,000 | - | 0 | Class A Common Stock | |
| Credit Acceptance Corp | Andrew K. Rostami | Chief Mktg and Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 528.12 per share. | 18 Apr 2026 | 473 | 23,090 (0%) | 0% | 528.1 | 249,800 | Common Stock |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 255.00 per share. | 17 Apr 2026 | 31,000 | 2,207,118 (0%) | 0% | 255 | 7,905,000 | Common Stock, par value $.01 per share |
| Camden National Corp | Andrew R. Forbes | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 15 Apr 2026 | 51 | 5,350 (0%) | 0% | 50.4 | 2,569 | Common Stock |
| J.Jill Inc | Andrew Rolfe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2026 | 8,285 | 27,627 (0%) | 0% | 0 | Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.05 per share. | 01 Apr 2026 | 45,000 | 3,911,368 (221%) | 2% | 11.1 | 497,277 | Class A-1 Common Stock |
| Hagerty Inc (Class A) | Russell Andrew Page | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 30,865 | 142,889 | - | 0 | Class A Common Stock | |
| Hagerty Inc (Class A) | Russell Andrew Page | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.66 per share. | 01 Apr 2026 | 11,146 | 131,743 | - | 10.7 | 118,816 | Class A Common Stock |
| ARKO Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 6,118 | 168,332 | - | - | Restricted Stock Units | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.27 per share. | 01 Apr 2026 | 5,000 | 46,382 (0%) | 0% | 52.3 | 261,350 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 5,000 | 49,444 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 199.72 per share. | 01 Apr 2026 | 1,302 | 44,620 (0%) | 0% | 199.7 | 260,038 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 200.94 per share. | 01 Apr 2026 | 1,238 | 43,382 (0%) | 0% | 200.9 | 248,767 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 203.22 per share. | 01 Apr 2026 | 963 | 41,719 (0%) | 0% | 203.2 | 195,703 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 201.90 per share. | 01 Apr 2026 | 700 | 42,682 (0%) | 0% | 201.9 | 141,328 | Common Stock |
| TREX Co. Inc | B. Andrew Rose | Director | Grant, award, or other acquisition of securities at price $ 36.57 per share. | 01 Apr 2026 | 700 | 14,883 (0%) | 0% | 36.6 | 25,599 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 198.85 per share. | 01 Apr 2026 | 460 | 45,922 (0%) | 0% | 198.9 | 91,471 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 204.50 per share. | 01 Apr 2026 | 337 | 41,382 (0%) | 0% | 204.5 | 68,917 | Common Stock |
| Chart Ind Inc | Andrew R. Cichocki | Director, Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 193 | 3,655 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 18.14 per share. | 31 Mar 2026 | 2,750 | 16,444 (0%) | 0% | 18.1 | 49,877 | Common Stock, par value $0.01 per share |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Grant, award, or other acquisition of securities at price $ 18.77 per share. | 31 Mar 2026 | 932 | 17,376 (0%) | 0% | 18.8 | 17,490 | Common Stock, par value $0.01 per share |
| Camden National Corp | Andrew R. Forbes | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 507 | 5,401 (0%) | 0% | 0 | Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.23 per share. | 17 Mar 2026 | 3,938 | 3,956,368 (224%) | 0% | 11.2 | 44,223 | Class A-1 Common Stock |
| Wealthfront Corp | Andrew S. Rachleff | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 29,762 | 29,762 | - | 0 | Common Stock | |
| Wealthfront Corp | Andrew S. Rachleff | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 29,762 | 0 | - | - | Restricted Stock Units | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 102,030 | 418,217 | - | - | Performance-based Restricted Stock Unit (PSU) | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 102,030 | 4,009,648 (227%) | 5% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.29 per share. | 14 Mar 2026 | 44,486 | 3,965,162 (224%) | 2% | 11.3 | 502,247 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.21 per share. | 14 Mar 2026 | 36,062 | 3,960,306 (224%) | 2% | 11.2 | 404,432 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 30,132 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 30,132 | 4,000,262 (226%) | 1% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 26,835 | 4,015,194 (227%) | 1% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 26,835 | 26,835 | - | - | Restricted Stock Unit (RSU) | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.29 per share. | 14 Mar 2026 | 11,903 | 3,988,359 (226%) | 0% | 11.3 | 134,385 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.29 per share. | 14 Mar 2026 | 11,701 | 4,003,493 (226%) | 0% | 11.3 | 132,104 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2026 | 7,125 | 3,996,368 (226%) | 0% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 6,958 | 3,972,120 (225%) | 0% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2026 | 6,958 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.29 per share. | 14 Mar 2026 | 1,990 | 3,970,130 (225%) | 0% | 11.3 | 22,467 | Class A-1 Common Stock |
| GrafTech Intl Ltd | Andrew James Renacci | CLO and Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 1,800 | 9,417 (0%) | 0% | - | Common Stock | |
| GrafTech Intl Ltd | Andrew James Renacci | CLO and Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 1,800 | 1,800 | - | - | Restricted Stock Units | |
| GrafTech Intl Ltd | Andrew James Renacci | CLO and Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.23 per share. | 12 Mar 2026 | 526 | 8,891 (0%) | 0% | 5.2 | 2,751 | Common Stock |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 207,853 | 545,162 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Mar 2026 | 55,419 | 489,743 (0%) | 0% | 0 | Common Stock | |
| NCR Atleos Corp | R. Andrew Wamser | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 44.56 per share. | 10 Mar 2026 | 45,277 | 142,777 | - | 44.6 | 2,017,543 | Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 29,345 | 58,689 | - | - | Restricted Stock Unit (RSU) | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 29,345 | 3,918,166 (222%) | 1% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.45 per share. | 10 Mar 2026 | 10,548 | 3,907,618 (221%) | 0% | 11.5 | 120,775 | Class A-1 Common Stock |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.40 per share. | 10 Mar 2026 | 7,267 | 482,476 (0%) | 0% | 80.4 | 584,267 | Common Stock |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.63 per share. | 10 Mar 2026 | 6,687 | 475,789 (0%) | 0% | 79.6 | 532,486 | Common Stock |
| CBRE (Class A) | Andrew R. Glanzman | CEO, Real Estate Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.59 per share. | 10 Mar 2026 | 869 | 56,471 (0%) | 0% | 134.6 | 116,959 | Class A Common Stock |
| CBRE (Class A) | Andrew R. Glanzman | CEO, Real Estate Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.59 per share. | 10 Mar 2026 | 817 | 57,340 (0%) | 0% | 134.6 | 109,960 | Class A Common Stock |
| Symbotic Inc (Class A) | Andrew D. Ross | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 5,104 | 5,104 | - | - | Class A Common Stock | |
| Symbotic Inc (Class A) | Andrew D. Ross | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 5,104 | 0 | - | - | Restricted Stock Units | |
| Symbotic Inc (Class A) | Andrew D. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 4,738 | 4,738 | - | - | Restricted Stock Units | |
| CBRE (Class A) | Andrew R. Glanzman | CEO, Real Estate Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.19 per share. | 05 Mar 2026 | 785 | 58,157 (0%) | 0% | 141.2 | 110,834 | Class A Common Stock |
| CBRE (Class A) | Andrew R. Glanzman | CEO, Real Estate Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.19 per share. | 05 Mar 2026 | 739 | 58,942 (0%) | 0% | 141.2 | 104,339 | Class A Common Stock |
| Camden National Corp | Andrew R. Forbes | EVP | Grant, award, or other acquisition of securities at price $ 34.58 per share. | 05 Mar 2026 | 733 | 4,894 (0%) | 0% | 34.6 | 25,347 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.27 per share. | 04 Mar 2026 | 5,000 | 41,869 (0%) | 0% | 52.3 | 261,350 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 5,000 | 54,444 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 208.12 per share. | 04 Mar 2026 | 1,446 | 38,011 (0%) | 0% | 208.1 | 300,939 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 208.87 per share. | 04 Mar 2026 | 1,142 | 36,869 (0%) | 0% | 208.9 | 238,532 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 207.01 per share. | 04 Mar 2026 | 612 | 39,457 (0%) | 0% | 207.0 | 126,689 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 205.18 per share. | 04 Mar 2026 | 460 | 40,409 (0%) | 0% | 205.2 | 94,382 | Common Stock |